WASHINGTON, D.C. (WANE) The Food and Drug Administration (FDA) on Wednesday issued a request for the removal of all prescription and over-the-counter (OTC) ranitidine drugs commonly known as Zantac ...
WASHINGTON, D.C. – The U.S. Food and Drug Administration (FDA) is requesting that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market. The ...
Earlier this week, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% ...
The French pharmaceutical company Sanofi says it has reached an agreement to resolve 4,000 cases in the U.S., in which plaintiffs are linking the discontinued heartburn drug Zantac — and its active ...
On Wednesday, GSK plc (NYSE:GSK) reached agreements with ten plaintiff firms representing approximately 80,000 Zantac product liability cases in the U.S. state courts. These cases account for 93% of ...
Apotex Corp. Issues Voluntary Nationwide Recall of Ranitidine Tablets 75mg and 150mg (All pack sizes
Apotex Corp. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) to the Retail level. Apotex has learned from the U.S. Food and Drug ...
Settlement resolves 80,000 or 93% of pending US cases GSK top gainer on FTSE-100, best one-day gain since Dec 2022 To record 1.8 billion pounds charge in Q3 results Oct 10 (Reuters) - GSK (GSK.L), ...
Cancer affects roughly one in three women and one in three men in the United States, and last year, there were an estimated 1,762,450 new cases of cancer reported on record. While the types of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results